The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC).
 
Fergus Keane
No Relationships to Disclose
 
Lily Saadat
No Relationships to Disclose
 
Catherine O'Connor
No Relationships to Disclose
 
Joanne F. Chou
No Relationships to Disclose
 
Angela Rose Brannon
Stock and Other Ownership Interests - Johnson & Johnson
 
Darren Cowzer
No Relationships to Disclose
 
Fionnuala Crowley
No Relationships to Disclose
 
Neha Debnath
No Relationships to Disclose
 
Anita Bowman
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Wungki Park
Consulting or Advisory Role - Cerner Enviza; onconic therapeutics
Research Funding - Astellas Pharma (Inst); Merck (Inst)
 
Alice Zervoudakis
No Relationships to Disclose
 
Fiyinfolu Balogun
Honoraria - Mediflix (I)
Patents, Royalties, Other Intellectual Property - Mission Driven Tech. Brachytherapy (I)
 
Anna M. Varghese
Consulting or Advisory Role - Lilly (I); Roche (I)
Research Funding - BioMed Valley Discoveries; Bristol-Myers Squibb; Illumina (I); Lilly; Silenseed; Verastem
Travel, Accommodations, Expenses - Roche (I)
 
Kenneth H. Yu
Consulting or Advisory Role - Ipsen
Research Funding - General Oncology (Inst); Ipsen; OncoC4 (Inst); Senhwa Biosciences (Inst)
 
David Paul Kelsen
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - AstraZeneca; Lilly; PetDx
Patents, Royalties, Other Intellectual Property - Provisional patent pending for "Systems and Methods for Detecting Cancer via cfDNA Screening"
 
Alice Chia-chi Wei
Honoraria - AstraZeneca Canada; Medtronic
Consulting or Advisory Role - Biosapien; Histosonics
 
Eileen Mary O'Reilly
Consulting or Advisory Role - AstraZeneca; Autem Medical (I); Boehringer Ingelheim; Eisai (I); Exelixis (I); Genentech/Roche (I); Helio Health (I); Incyte (I); Ipsen; Merck; Novartis; QED Therapeutics (I); Yiviva (I); Yiviva (I)
Research Funding - Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Bristol Myers Squibb (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Helsinn Healthcare (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Roche (Inst); Yiviva (Inst)
(OPTIONAL) Uncompensated Relationships - Thetis Pharma